Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference21 articles.
1. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma;Richardson;N Engl J Med.,2005
2. Bortezomib continues to demonstrate superior efficacy compared with high-dose dexamethasone in relapsed multiple myeloma: updated results of the APEX trial;Richardson;Blood.,2005
3. Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial;Richardson;Blood.,2007
4. Proteasome inhibitors: a novel class of potent and effective antitumor agents;Adams;Cancer Res.,1999
5. Protein degradation and protection against misfolded or damaged proteins;Goldberg;Nature.,2003
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1;Frontiers in Immunology;2021-02-25
2. Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis;Blood Cancer Journal;2020-03
3. Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China;Medicine;2019-09
4. Pharmacodynamics and pharmacokinetics of proteasome inhibitors for the treatment of multiple myeloma;Expert Opinion on Drug Metabolism & Toxicology;2019-05-31
5. Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial;Clinical Cancer Research;2019-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3